Immunogenicity and safety of inactivated hepatitis A vaccines in Chinese healthy population over 2 ;years of age

黄腾,李艳萍,万宗举,毛群颖,高佳梅,蔡祥勇,董延秀,朱昌林,姜春来,魏巍,万铁军,郭丽姝,孙会来,曾志,王忠诚

DOI: https://doi.org/10.3969/j.issn.1673-758X.2016.03.001

2016-01-01

Abstract:Objective To evaluate immunogenicity and safety of inactivated hepatitis A vaccine (Vero cell) and hepatitis A vaccine (Diploid cell) in Chinese healthy population over 2 years of age. Methods A randomized , blind, controlled trial involving 2100 healthy subjects over 2 years of age was conducted into group A or B, two dose of hepatitis A vaccine (Vero cell) or hepatitis A vaccine (Diploid cell) were vaccinated with a 6 months interval between doses, and observed for safety. Serum samples before the 1st dose,1 month after 1st dose( only 600 subjects) and 1 month after immunization were collected, tested by ELISA. Results After 1st dose, the seroconversion rates of A group were 96.05%(adults) and 92.78%(children),B group were 94.92%(adults) and 96.61%(children). After two doses, A group were 99.61% (adults) and 99.53% (children) ,B group were 99.41% (adults) and 100.00%(children) .There was no significantly statistical difference between the two groups. The total incidence of adverse reaction of A group were 32.41% (adults) and 53.61% (children) ,which was no significantly statistical difference compared with B group, 35.56% (adults) and 53.33% (children) , and major side effects were mild. Conclusion The immunogenicity of inactivated Hepatitis A Vaccine (Vero cell) was non-inferiority to Hepatitis A Vaccine (Diploid cell),and with the same result in safety.